Shiezoli · Nov 11, 2026

Shiezoli — video status

The FDA is now requiring the makers of GLP-1 drugs like Ozempic, Wegovy and Zepbound to add a warning to labels because of a possible link to rare and irreversible vision loss. CBS News chief medical correspondent Dr. LaPook explains the symptoms, who may be at risk and what patients need to ask their doctors.

More from Shiezoli

• 
  ShiezoliNov 13, 2026 · “Team Hamas says what?” Sen. John Fetterman calls out an ant
• 
  ShiezoliNov 13, 2026 · SMITH: "Over 300,000 lost their federal jobs. You told me—"
• 
  ShiezoliNov 13, 2026 · No, it's not snow! Massive piles of hail blanketed parts of
• 
  ShiezoliNov 12, 2026 · POTUS on a hypothetical matchup between him and Barack Husse
• 
  ShiezoliNov 12, 2026 · Steve Bannon on Iran War: President Trump never really went
• 
  ShiezoliNov 12, 2026 · TERRIFYING FOOTAGE: The horrifying moment the building colla